[1]Bosman FT,Garneiro F,Hruban RH,et al.WHO classification of tumors of the digestive system[M].Lyon:IARC Press,2010:11-20.
[2]Chinese Gastroenteropancreatic Neuroendocrine Neoplasm Pathology Expert Group.Consensus opinion on pathological diagnosis of gastroenteropancreatic neuroendocrine neoplasm in China[J].Chin J Pathol,2011,40(4):257-262.[中国胃肠胰神经内分泌肿瘤病理专家组.中国胃肠胰神经内分泌肿瘤病理学诊断共识意见[J].中华病理学杂志,2011,40(4):257-262.]
[3]Cho MY,Kim JM,Sohn JH,et al.Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors(GEP-NETs)in Korea 2000-2009:Multicenter study[J].Cancer Res Treat,2012,44(3):157-165.
[4]Lin HH,Lin JK,Jiang JK,et al.Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes[J].World Joural of Surgical Oncology,2014,12(1):366.
[5]Kojima M,Ikeda K,Saito N,et al.Neuroendocrine tumors of the large intestine:Clinicopathological features and predictive factors of lymph node metastasis[J].Front Oncol,2016,6(173):3389.
[6]Soga J.Early-stage carcinoids of the gastrointestinal tract:An analysis of 1 914 reported cases[J].Cancer,2005,103(8):1587-1595.
[7]Untch BR,Bonner KP,Roggin KK,et al.Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors[J].J Gastrointest Surg,2014,18(3):457-462.
[8]Landry CS,Brock G,Scoggins CR,et al.A proposed staging system for rectal carcinoid tumors based on an analysis of 4 701 patients[J].Surgery,2008,144(3):460-466.
[9]Mitsuhashi K,Yamamoto I,Kurihara H,et al.Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy[J].Oncotarget,2015,6(26):22114-22125.
[10]Jetmore AB,Ray JE,Gathright JB Jr,et al.Rectal carcinoids.The most frequent carcinoid tumors[J].Dis Colon Rectum,1992,35(8):717-725.
[11]Naunheim KS,Zeitels J,Kaplan EL,et al.Rectal carcinoid tumors.Treatment and prognosis[J].Surgery,1983,94(4):670-676.
[12]Nagata K,Tajiri K,Shimada S,et al.Rectal neuroendocrine tumor G1 with a solitary hepatic metastatic lesion[J].Intern Med,2017,56(3):289-293.
[13]Xu G,Wang P,Xiao Y,et al.Local resection of rectal neuroendocrine tumor with first clinical manifestation of giant liver metastasis by transanal endoscopic microsurgery:A case report[J].Medicine,2017,96(50):e9153.
[14]Sun W,Lipsitz S,Catalano P,et al.Phase Ⅱ/Ⅲ study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors:Eastern cooperative oncology group study E1281[J].J Clin Oncol,2005,23(22):4897-4904.
[15]Starzynska T,Londzin-Olesik M,Baldys-Waligorska A,et al.Colorectal neuroendocrine neoplasms:Management guidelines (recommended by the Polish Network of Neuroendocrine Tumours)[J].Endokrynol Pol,2017,68(2):250-260.
[16]Yamashina T,Tumura T,Maruo T,et al.Underwater endoscopic mucosal resection:A new endoscopic method for resection of rectal neuroendocrine tumor grade1(carcinoid)≤10 mm in diameter[J].Endosc Int Open,2018,6(1):E111-E114.
[17]Takatsu Y,Fukunaga Y,Nagasaki T,et al.Short-and long-term outcomes of laparoscopic total mesenteric excision for neuroendocrine tumors of the rectum[J].Dis Colon Rectum,2017,60(3):284-289.